Cargando…

1004. Dalbavancin Use and Associated Cost-Savings: An Update

BACKGROUND: Dalbavancin provides an alternative to standard of care intravenous (IV) antibiotics for the treatment of complicated infections, although clinical data continues to evolve In the United States, the use of dalbavancin as an alternative for patients requiring long courses of IV therapy ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Streifel, Amber C, Sikka, Monica K, Lewis, James S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752204/ http://dx.doi.org/10.1093/ofid/ofac492.845

Ejemplares similares

1028. Dalbavancin Use in Complicated Infections and-associated Cost-Savings
por: Streifel, Amber C, et al.
Publicado: (2019)

625. The Hidden Cost of Dalbavancin: OPAT-RN Time Spent on Coordination for Patients with Substance Use Disorder
por: Douglass, Alyse, et al.
Publicado: (2021)

1268. Dalbavancin for the Treatment of Infections due to Staphylococcus aureus
por: Streifel, Amber C, et al.
Publicado: (2020)

122. Dalbavancin Use in Patients with Substance Use Disorders
por: Streifel, Amber C, et al.
Publicado: (2020)

The hidden cost of dalbavancin: OPAT RN time required in coordination for persons who use drugs
por: Douglass, Alyse H., et al.
Publicado: (2023)

Transition of Care with Dalbavancin: a Successful Cost-Saving Stewardship Program through Decreased Length of Stay
por: Terriff, Colleen
Publicado: (2017)

108. Evaluation of the Impact of Dalbavancin Usage on Clinical Outcomes, Cost-Savings, and Adherence at a Large Safety Net Hospital
por: Wei, Wenjing, et al.
Publicado: (2021)

188. Outcomes After Implementing the OPTIONS-DC Multidisciplinary Care Conference for Patients with Substance Use Disorders and Severe Bacterial Infections
por: Schneider, Brenton J, et al.
Publicado: (2021)

1801. About Damn Time: HAV, HBV, and Tetanus Screening and Vaccination during Hospitalization in Persons who Use Drugs
por: Streifel, Amber C, et al.
Publicado: (2023)

597. Comparison of Vancomycin and Daptomycin Complications and Interventions in Outpatient Parenteral Antimicrobial Therapy
por: Nakrani, Monark, et al.
Publicado: (2020)

Evaluation of Dalbavancin Use on Clinical Outcomes, Cost-Savings, and Adherence at a Large Safety Net Hospital
por: Lueking, Richard, et al.
Publicado: (2022)

2902. Dalbavancin Use in Bone and Joint Infections
por: Sanikommu, Srivani, et al.
Publicado: (2023)

1762. A Review of Antibiotic Outcomes Data Utilizing the Multidisciplinary OPTIONS-DC Conference for PWUD
por: Douglass, Alyse H, et al.
Publicado: (2022)

1385. Pathway with single-dose long-acting intravenous antibiotic dalbavancin is a cost-saving alternative to usual inpatient care of acute bacterial skin and skin structure infections (ABSSSI)
por: Lovecchio, Frank, et al.
Publicado: (2022)

The challenge of antibiotic selection in prosthetic joint infections due to Corynebacterium striatum: a case report
por: Streifel, Amber C., et al.
Publicado: (2022)

614. Evaluating the Use of Dalbavancin for Off-Label Indications
por: Taylor, Katherine, et al.
Publicado: (2021)

1004. Interactive Dashboards for Antimicrobial Usage and Standardized Antimicrobial Administration Ratio Data
por: Percival, Kelly M, et al.
Publicado: (2019)

1004. Cladophora in Lake Michigan May Serve as Important Reservoirs for Antibiotic-Resistant Bacteria
por: Grayer, Dannielle C, et al.
Publicado: (2021)

Asthma diagnosis and treatment – 1004. The utility of mannitol challenge in the assessment of asthma
por: Antolin-Amerigo, Dario, et al.
Publicado: (2013)

2764. Experience with dalbavancin in a pediatric hospital
por: Leon, Maria Deza, et al.
Publicado: (2023)

1730. Real-World Use Of Dalbavancin In A US Tertiary Referral Center
por: Bhugra, Mudita, et al.
Publicado: (2022)

Screening for co-infections in patients with substance use disorders and severe bacterial infections
por: Varley, Cara D., et al.
Publicado: (2022)

1828. Dalbavancin Utilization and Associated Clinical Outcomes: A Case-Series
por: Greckel, Meagan N, et al.
Publicado: (2022)

1004 ejercicios de flexibilidad
por: Ibáñez Riestra, Ascensión
Publicado: (2008)

1004 ejercicios de flexibilidad
por: Ibáñez Riestra, Ascensión
Publicado: (1994)

Description and outcomes of patients with substance use disorder with serious bacterial infections who had a multidisciplinary care conference
por: Conte, Michael, et al.
Publicado: (2022)

225. Dalbavancin Usage in Patients Who Inject Drugs (PWID)
por: Patel, Kaya, et al.
Publicado: (2023)

Evaluation of Dalbavancin and Oritavancin as Cost-Effective Treatments of Acute Bacterial Skin and Skin Structure Infections in Hospitalized Patients
por: Koutsari, Christina, et al.
Publicado: (2017)

1004 Technical and Logistical Issues in Incorporating Statistical Process Control into Healthcare-Associated Infection Surveillance Programs
por: Baker, Arthur W., et al.
Publicado: (2014)

Dalbavancin
por: Barberán, José, et al.
Publicado: (2021)

438. Dalbavancin Clinical Experience at an NCI Designated Cancer Center
por: McDaneld, Patrick, et al.
Publicado: (2019)

2255. The Use of Dalbavancin for Staphylococcus aureus Bacteremia in Persons Who Inject Drugs (PWID)
por: Van Hise, Nicholas W, et al.
Publicado: (2019)

687. Use of Dalbavancin in Gram-positive Infective Endocarditis: Review of Current Literature
por: Fazili, Tasaduq, et al.
Publicado: (2021)

2765. Dalbavancin for challenging left ventricular assist device driveline infections
por: Doligalski, Christina, et al.
Publicado: (2023)

267 Dalbavancin for the treatment of Streptococcal Skin Infections
por: Puttagunta, Sailaja, et al.
Publicado: (2014)

1286. Evaluating Dalbavancin Suppression Therapy in Patients at High Risk for Recurrent Infections
por: Shaw, Michael, et al.
Publicado: (2023)

314. A Retrospective Review of Dalbavancin Utilization at an Academic Medical Center
por: Napoli, Emma, et al.
Publicado: (2020)

1015. Real World Use of Dalbavancin and Oritavancin for Optimized Outpatient Antimicrobial Therapy in Patients Inappropriate for Standard Therapy
por: Weichman, Brittani, et al.
Publicado: (2022)

1004. Frequency of Occurrence and Antimicrobial Susceptibility of Bacteria Isolated From Patients Hospitalized With Bloodstream Infections in United States Medical Centers (2015–2017)
por: Sader, Helio S, et al.
Publicado: (2018)

Hospital Discharge Interventions: A Cost-Savings Comparison
por: Albright, Bonnie, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_va6haapbjhcg5sj9jfv34b6jco